APA (7th ed.) Citation

Bissonnette, R., Bolduc, C., Maari, C., Nigen, S., Webster, J., Tang, L., & Lyle, M. (2012). Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: Results from a randomized double-blind placebo-controlled, phase II trial. Journal of the European Academy of Dermatology & Venereology, 26(12), 1516. https://doi.org/10.1111/j.1468-3083.2011.04332.x

Chicago Style (17th ed.) Citation

Bissonnette, R., C. Bolduc, C. Maari, S. Nigen, J.M Webster, L. Tang, and M. Lyle. "Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Moderate Psoriasis: Results from a Randomized Double-blind Placebo-controlled, Phase II Trial." Journal of the European Academy of Dermatology & Venereology 26, no. 12 (2012): 1516. https://doi.org/10.1111/j.1468-3083.2011.04332.x.

MLA (9th ed.) Citation

Bissonnette, R., et al. "Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Moderate Psoriasis: Results from a Randomized Double-blind Placebo-controlled, Phase II Trial." Journal of the European Academy of Dermatology & Venereology, vol. 26, no. 12, 2012, p. 1516, https://doi.org/10.1111/j.1468-3083.2011.04332.x.